STATUTORY RULES.
1962. No. 114.
–––––––––
REGULATIONS UNDER THE NATIONAL HEALTH ACT 1953-1962.*
I, THE GOVERNOR-GENERAL in and over the Commonwealth of Australia, acting with the advice of the Federal Executive Council, hereby make the following Regulations under the National Health Act 1953-1962.
Dated this twenty-first
day of December, 1962.
Governor-General.
By His Excellency’s Command,
(SGD.) H. W. WADE
Minister of State for Health.
––––––
Amendments of the National Health (Pharmaceutical Benefits) Regulations.†
Commencement.
1. These Regulations shall come into operation on the first day of January, 1963.
Second Schedule.
2. The Second Schedule to the National Health (Pharmaceutical Benefits) Regulations is amended—
(a) by omitting the words—
“Ergotamine Tartrate B.P. | Ergotamine Tartrate B.P. with Caffeine B.P. Ergotamine Tartrate B.P. with Caffeine Citrate B.P.C. and Diphenhydramine Hydrochloride B.P. Ergotamine Tartrate B.P. with Caffeine B.P. and Meclozine Hydrochloride B.P.” |
and inserting in their stead the words— | |
“ Ergotamine Tartrate B.P. | Ergotamine Tartrate B.P. with Caffeine B.P. Ergotamine Tartrate B.P. with Caffeine Citrate B.P.C. and Diphenhydramine Hydrochloride B.P.”; and |
(b) by omitting the words and symbol— | |
“ Meclozine Hydrochloride B.P.C. .. .. |
—,”. |
* Notified in the Commonwealth Gazette on 24th December, 1962.
† Statutory Rules 1960, No. 17, as amended by Statutory Rules 1960, Nos. 90 and 102; 1961, Nos. 59 and 137; and 1962, Nos. 34 and 101.
11233/62.—Price 3d. 10/13.12.1962.
Third Schedule.
3. The Third Schedule to the National Health (Pharmaceutical Benefits) Regulations is amended by omitting the words “Meclozine Hydrochloride, B.P.C.”.
Fifth Schedule
4. The Fifth Schedule to the National Health (Pharmaceutical Benefits) Regulations is amended by inserting after the words—
“Methicillin...................... | Any disease or condition in a patient receiving treatment in or at an approved hospital” |
the words— | |
“Methotrexate.................... | The leukaemias and neo-plastic disease”. |
––––––––––––
By Authority: A. J. Arthur, Commonwealth Government Printer, Canberra.